Bank Of America Corp Aytu Biopharma, Inc Transaction History

Bank Of America Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.15 - $4.0 $35 - $956	239 Added 21.81%	1,335 $0
Q3 2022 Nov 14, 2022	SELL	$0.19 - $3.8 $19 - $380	-100 Reduced 8.36%	1,096 $0
Q4 2021 Feb 08, 2022	SELL	$1.35 - $2.95 $7,453 - $16,286	-5,521 Reduced 82.19%	1,196 $2,000
Q3 2021 Nov 15, 2021	SELL	$2.78 - $5.12 $49,534 - $91,228	-17,818 Reduced 72.62%	6,717 $19,000
Q2 2021 Sep 13, 2021	BUY	$4.73 - $7.56 $116,050 - $185,484	24,535 New	24,535 $123,000

Ticker AYTU
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 62,432,700
Market Cap $88.7M
Description
Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT f...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.